Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Fish and Richardson
Mallinckrodt
Julphar
Federal Trade Commission
Harvard Business School
McKinsey
QuintilesIMS
UBS

Generated: April 23, 2018

DrugPatentWatch Database Preview

HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE Drug Profile

« Back to Dashboard

Which patents cover Hydralazine Hydrochloride And Hydrochlorothiazide, and what generic alternatives are available?

Hydralazine Hydrochloride And Hydrochlorothiazide is a drug marketed by Solvay, Superpharm, and Watson Labs. and is included in eight NDAs.

The generic ingredient in HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE is hydralazine hydrochloride; hydrochlorothiazide. There are twenty drug master file entries for this compound. Additional details are available on the hydralazine hydrochloride; hydrochlorothiazide profile page.
Summary for HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
Drug patent expirations by year for HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

US Patents and Regulatory Information for HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Solvay HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydralazine hydrochloride; hydrochlorothiazide CAPSULE;ORAL 087608-001 Feb 8, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydralazine hydrochloride; hydrochlorothiazide CAPSULE;ORAL 085446-001 Mar 4, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Superpharm HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydralazine hydrochloride; hydrochlorothiazide CAPSULE;ORAL 089200-001 Feb 9, 1987 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydralazine hydrochloride; hydrochlorothiazide CAPSULE;ORAL 085440-001 Mar 4, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Queensland Health
Medtronic
McKinsey
Dow
Healthtrust
Argus Health
Teva
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.